login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ATRICURE INC (ATRC) Stock News
USA
-
Nasdaq
- NASDAQ:ATRC -
US04963C2098
-
Common Stock
41.04
USD
-1.34 (-3.16%)
Last: 12/15/2025, 4:30:01 PM
41.04
USD
0 (0%)
After Hours:
12/15/2025, 4:30:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ATRC Latest News, Press Relases and Analysis
All
Press Releases
4 days ago - By: AtriCure, Inc.
AtriCure Announces the First Patients Treated with Novel Dual Energy Platform
7 days ago - By: Zacks Investment Research
- Mentions:
BSX
Are Medical Stocks Lagging AtriCure (ATRC) This Year?
16 days ago - By: The Motley Fool
Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares?
2 months ago - By: Benzinga
- Mentions:
CGO
ROL
ESRT
NNBR
...
Earnings Scheduled For October 29, 2025
5 months ago - By: The Motley Fool
AtriCure (ATRC) Q2 Revenue Jumps 17%
25 days ago - By: Zacks Investment Research
- Mentions:
CDTX
Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year?
a month ago - By: AtriCure, Inc.
AtriCure to Participate in the Piper Sandler 37th Annual Healthcare Conference
a month ago - By: Zacks Investment Research
AtriCure (ATRC) Loses 13.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
a month ago - By: Zacks Investment Research
Here's What Key Metrics Tell Us About AtriCure (ATRC) Q3 Earnings (Revised)
8 months ago - By: Benzinga
14 Analysts Assess AtriCure: What You Need To Know
a month ago - By: Zacks Investment Research
- Mentions:
CABA
Is AtriCure (ATRC) Outperforming Other Medical Stocks This Year?
2 months ago - By: Zacks Investment Research
Here's What Key Metrics Tell Us About AtriCure (ATRC) Q3 Earnings
2 months ago - By: Zacks Investment Research
AtriCure (ATRC) Reports Q3 Loss, Beats Revenue Estimates
2 months ago - By: AtriCure, Inc.
AtriCure Reports Third Quarter 2025 Financial Results; Raises Financial Outlook for 2025
2 months ago - By: AtriCure, Inc.
AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial
2 months ago - By: AtriCure, Inc.
AtriCure to Participate in Upcoming Investor Conferences
2 months ago - By: AtriCure, Inc.
AtriCure to Announce Third Quarter 2025 Financial Results
3 months ago - By: AtriCure, Inc.
AtriCure Announces the Launch of the cryoXTâ„¢ Device for Post-Operative Pain Management Following Amputation
4 months ago - By: AtriCure, Inc.
AtriCure to Participate in the 2025 Wells Fargo Healthcare Conference
5 months ago - By: AtriCure, Inc.
AtriCure Reports Second Quarter 2025 Financial Results; Raises Financial Outlook for 2025
5 months ago - By: AtriCure, Inc.
AtriCure to Participate in the Canaccord Genuity 45th Annual Growth Conference
5 months ago - By: AtriCure, Inc.
AtriCure Completes Enrollment in LeAAPS Clinical Trial for Stroke Prevention
5 months ago - By: AtriCure, Inc.
AtriCure to Announce Second Quarter 2025 Financial Results
7 months ago - By: Zacks Investment Research
Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year?
7 months ago - By: AtriCure, Inc.
AtriCure to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
7 months ago - By: Zacks Investment Research
Does AtriCure (ATRC) Have the Potential to Rally 54.7% as Wall Street Analysts Expect?
Please enable JavaScript to continue using this application.